Siddarth Chandrasekaran

Title: Siddarth Chandrasekaran: Innovator in Immunomodulatory Antibodies

Introduction

Siddarth Chandrasekaran is a prominent inventor based in Issaquah, WA (US). He has made significant contributions to the field of immunology, particularly in the development of antibodies that target specific cellular markers. With a total of 4 patents to his name, his work is paving the way for innovative treatments in cancer therapy.

Latest Patents

Chandrasekaran's latest patents include groundbreaking work on immunomodulatory antibodies. One of his notable patents is titled "Immunomodulatory antibodies and methods of use thereof." This patent describes antibodies that bind to CD163 on cells, such as macrophages, and outlines methods for using these antibodies in cancer treatment. Another significant patent is "Human CD163 antibodies and uses thereof," which similarly focuses on the therapeutic potential of antibodies that target CD163, emphasizing their application in treating cancer.

Career Highlights

Siddarth Chandrasekaran is currently associated with OncoResponse, Inc., a company dedicated to advancing cancer therapies through innovative research. His role at OncoResponse allows him to leverage his expertise in antibody development to contribute to the company's mission of improving patient outcomes.

Collaborations

Chandrasekaran collaborates with talented professionals in his field, including Kamal D Puri and Melissa L Conerly. These collaborations enhance the research and development efforts at OncoResponse, fostering an environment of innovation and discovery.

Conclusion

Siddarth Chandrasekaran is a key figure in the development of immunomodulatory antibodies, with a focus on cancer treatment. His patents and work at OncoResponse highlight his commitment to advancing medical science and improving therapeutic options for patients.